Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | PFE | MRNA |
|---|---|---|---|
| Return | |||
| Last Price | 54.70 | 28.44 | 144.99 |
| Daily Change | — | − 1.28% | − 2.61% |
| Period ReturnPast 6 Months | — | + 4.98% | + 181.47% |
| Valuation | |||
| Market Cap | $4.50 B | $162 B | $57.5 B |
| P/E Ratio | — | 37.65 | — |
| Dividend Yield | — | 5.38% | — |
| Net MarginTrailing 12M | — | 6.8% | — |
| Risk | |||
| Beta | 0.90 | 0.28 | — |
| 52-Week Range | 41.77 — $54.83 | 23.58 — $29.21 | — |
| Company | |||
| Sector | — | Health Care | Health Care |
| Industry | Biotechnology | Pharmaceuticals | Biotechnology |
Company
- AKROBiotechnology
- PFEHealth Care · Pharmaceuticals
- MRNAHealth Care · Biotechnology
Metrics could not be loaded for MRNA: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 02:5215 Minutes Delayed
To Understand This